E
Y. Zi et al.
Cluster
Synlett
Meegan, M. J. Bioorg. Med. Chem. 2011, 19, 2306. (c) Zhou, P.;
Liang, Y.; Zhang, H.; Jiang, H.; Feng, K.; Xu, P.; Wang, J.; Wang,
X.; Ding, K.; Luo, C. Eur. J. Med. Chem. 2018, 144, 817.
cupreidine as the catalyst in toluene (1.5 equiv of carbonate)
and 20 mol% of (DHQD)2AQN as the catalyst in p-xylene in the
presence of CaF2 (2 equiv of carbonate). In comparison, our pro-
tocol uses a lower catalyst loading and avoids the use of super-
stoichiometric quantities of MBH carbonate, as is the case in
these two previous reports, see: (a) Formánek, B.; Šimek, M.;
Kamlar, M.; Císařová, I.; Veselý, J. Synthesis 2019, 51, 907.
(b) Zhao, S.; Chen, Z.-L.; Rui, X.; Gao, M.-M.; Chen, X. Synlett
2019, 703.
(4) Pitts, C. R.; Lectka, T. Chem. Rev. 2014, 114, 7930.
(5) (a) Zi, Y.; Lange, M.; Schultz, C.; Vilotijevic, I. Angew. Chem. Int.
Ed. 2019, 58, 10727. (b) Lange, M.; Zi, Y.; Vilotijevic, I. J. Org.
Chem. 2019, in press; DOI: 10.1021/acs.joc.9b02819.
(6) (a) Ma, G.-N.; Jiang, J.-J.; Shi, M.; Wei, Y. Chem. Commun. 2009,
5496. (b) Basavaiah, D.; Reddy, B. S.; Badsara, S. S. Chem. Rev.
2010, 110, 5447. (c) Wei, Y.; Shi, M. Chem. Rev. 2013, 113, 6659.
(d) Wei, Y.; Shi, M. Acc. Chem. Res. 2010, 43, 1005. (e) Xie, P.;
Huang, Y. Org. Biomol. Chem. 2015, 13, 8578. (f) Tang, Q.; Tu, A.;
Deng, Z.; Hu, M.; Zhong, W. Chin. J. Org. Chem. 2013, 33, 954.
(7) (a) Rajesh, S.; Banerji, B.; Iqbal, J. J. Org. Chem. 2002, 67, 7852.
(b) Kim, J.-M.; Kim, S.-H.; Kim, S.-H.; Kim, J.-N. Bull. Korean
Chem. Soc. 2008, 29, 1583. (c) Wang, X.; Meng, F.; Wang, Y.; Han,
Z.; Chen, Y. J.; Liu, L.; Wang, Z.; Ding, K. Angew. Chem. Int. Ed.
2012, 51, 9276. (d) Wang, Y.; Liu, L.; Wang, D.; Chen, Y.-J. Org.
Biomol. Chem. 2012, 10, 6908. (e) Wang, Y.; Zhang, T.; Liu, L.
Chin. J. Chem. 2012, 30, 2641. (f) Wang, X.; Guo, P.; Han, Z.;
Wang, X.; Wang, Z.; Ding, K. J. Am. Chem. Soc. 2013, 136, 405.
(g) Zhu, L.; Hu, H.; Qi, L.; Zheng, Y.; Zhong, W. Eur. J. Org. Chem.
2016, 2139. (h) Sundararaju, B.; Achard, M.; Bruneau, C. Chem.
Soc. Rev. 2012, 41, 4467.
(15) (a) Puylaert, P.; van Heck, R.; Fan, Y.; Spannenberg, A.;
Baumann, W.; Beller, M.; Medlock, J.; Bonrath, W.; Lefort, L.;
Hinze, S. Chem. Eur. J. 2017, 23, 8473. (b) Schömberg, F.; Zi, Y.;
Vilotijevic, I. Chem. Commun. 2018, 54, 3266. (c) Zi, Y.;
Schömberg, F.; Seifert, F.; Görls, H.; Vilotijevic, I. Org. Biomol.
Chem. 2018, 16, 6341.
(16) Enantioselective Allylation of Anilines; General Procedure
Carbonate 7 (1 equiv), aniline 8 (1.1 equiv) and (DHQD)2AQN
(10 mol%) were added to a vial containing a stir bar. The vial
was evacuated and refilled with nitrogen 3 times. The reaction
mixture was then stirred at room temperature after adding
cyclohexane (0.4 M). After completion of the reaction, the
solvent was removed under reduced pressure. The crude
residue was purified by column chromatography (eluent: 5%
ethyl acetate in petroleum ether).
(8) (a) Shi, M.; Xu, Y. M. Angew. Chem. Int. Ed. 2002, 41, 4507.
(b) Matsui, K.; Takizawa, S.; Sasai, H. J. Am. Chem. Soc. 2005, 127,
3680. (c) Masson, G.; Housseman, C.; Zhu, J. Angew. Chem. Int.
Ed. 2007, 46, 4614. (d) Shi, Y.-L.; Shi, M. Eur. J. Org. Chem. 2007,
2905. (e) Declerck, V.; Martinez, J.; Lamaty, F. Chem. Rev. 2009,
109, 1.
Methyl
late (9a)
2-{[(4-Chlorophenyl)amino](phenyl)methyl}acry-
Yield: 28 mg (94%); pale yellow oil; 93:7 er (determined by
HPLC analysis) [Phenomenex Lux Cellulose-1, n-hexane/i-
PrOH = 95:5, 1.0 mL/min, = 253 nm, tR (major) = 18.73 min, tR
1
(minor) = 14.92 min]. H NMR (300 MHz, CDCl3): = 7.48–7.27
(9) (a) Li, J.; Wang, X.; Zhang, Y. Tetrahedron Lett. 2005, 46, 5233.
(b) Zhang, T.-Z.; Dai, L.-X.; Hou, X.-L. Tetrahedron: Asymmetry
2007, 18, 1990. (c) Sun, W.; Ma, X.; Hong, L.; Wang, R. J. Org.
Chem. 2011, 76, 7826. (d) Ma, G.; Sibi, M. P. Org. Chem. Front.
2014, 1, 1152. (e) Yao, L.; Wang, C.-J. Adv. Synth. Catal. 2015,
357, 384. (f) Kamlar, M.; Císařová, I.; Hybelbauerová, S.; Veselý,
J. Eur. J. Org. Chem. 2017, 1926. (g) Dočekal, V.; Šimek, M.;
Dračínský, M.; Veselý, J. Chem. Eur. J. 2018, 24, 13441. (h) Li, Z.;
Frings, M.; Yu, H.; Raabe, G.; Bolm, C. Org. Lett. 2018, 20, 7367.
(i) Li, Z.; Frings, M.; Yu, H.; Bolm, C. Org. Lett. 2019, 21, 3119.
(10) Bordwell, F. G.; Algrim, D. J. J. Am. Chem. Soc. 1988, 110, 2964.
(11) (a) Bakthadoss, M.; Srinivasan, J.; Selvakumar, R. Aust. J. Chem.
2014, 67, 295. (b) Kim, J. N.; Lee, H. J.; Lee, K. Y.; Gong, J. H.
Synlett 2002, 173.
(m, 5 H), 7.18–7.04 (m, 2 H), 6.57–6.44 (m, 2 H), 6.40 (s, 1 H),
5.92 (s, 1 H), 5.39 (s, 1 H), 4.24 (s, 1 H), 3.72 (s, 3 H). 13C NMR (75
MHz, CDCl3): = 166.58, 145.23, 140.21, 139.80, 129.07, 128.88,
128.01, 127.51, 126.37, 122.60, 114.63, 59.13, 52.06.
(17) Cyclization to -Lactams 10; General Procedure
To a solution of 9 (1.0 equiv) in toluene was added Sn[HMDS]2
(1.5 equiv). The mixture was refluxed for 2 h and the solution
then cooled and concentrated. The residue was purified by flash
chromatography on silica gel (eluent: 5% ethyl acetate in petro-
leum ether) to afford the desired product.
(R)-1-(3-Methoxyphenyl)-3-methylene-4-phenylazetidin-2-
one (10i)
Yield: 14 mg (85%); white solid. IR (ATR): 2927, 2360, 1743,
1597, 1492, 1454, 1369, 1249, 1114, 848, 752 cm–1 1H NMR
.
(12) (a) Chen, H.-Y.; Patkar, L. N.; Ueng, S.-H.; Lin, C.-C.; Lee, A. S.-Y.
Synlett 2005, 2035. (b) Lee, C. G.; Lee, K. Y.; Lee, S.; Kim, J. N. Tet-
rahedron 2005, 61, 1493. (c) Lee, C.-G.; Gowrisankar, S.; Kim, J.-
N. Bull. Korean Chem. Soc. 2005, 26, 481. (d) Kim, S.-C.;
Gowrisankar, S.; Kim, J.-N. Bull. Korean Chem. Soc. 2005, 26,
1001. (e) Pathak, R.; Madapa, S.; Batra, S. Tetrahedron 2007, 63,
451. (f) Gowrisankar, S.; Lee, H. S.; Kim, J. M.; Kim, J. N. Tetrahe-
dron Lett. 2008, 49, 1670.
(400 MHz, CDCl3): = 7.46–7.32 (m, 5 H), 7.17 (t, J = 8.1 Hz, 1
H), 7.06 (t, J = 2.2 Hz, 1 H), 6.84 (dd, J = 8.0, 1.9 Hz, 1 H), 6.63
(dd, J = 8.2, 2.5 Hz, 1 H), 5.86 (t, J = 1.9 Hz, 1 H), 5.41 (d, J = 1.6
Hz, 1 H), 5.19 (d, J = 1.6 Hz, 1 H), 3.77 (s, 3 H). 13C NMR (101
MHz, CDCl3): = 161.01, 160.13, 149.77, 138.68, 136.45, 129.92,
129.10, 128.81, 126.61, 111.01, 110.11, 109.41, 103.00, 63.72,
55.28. HRMS (EI): m/z [M]+ calcd for C17H15NO2: 265.1103;
found: 265.1094.
(13) (a) Du, Y.; Han, X.; Lu, X. Tetrahedron Lett. 2004, 45, 4967.
(b) Lin, A.; Mao, H.; Zhu, X.; Ge, H.; Tan, R.; Zhu, C.; Cheng, Y.
Adv. Synth. Catal. 2011, 353, 3301. (c) Pei, C.-K.; Zhang, X.-C.;
Shi, M. Eur. J. Org. Chem. 2011, 4479. (d) Liu, T. Y.; Xie, M.; Chen,
Y. C. Chem. Soc. Rev. 2012, 41, 4101. (e) Zhao, M.-X.; Chen, M.-X.;
Tang, W.-H.; Wei, D.-K.; Dai, T.-L.; Shi, M. Eur. J. Org. Chem. 2012,
3598. (f) Putaj, P.; Tichá, I.; Císařová, I.; Veselý, J. Eur. J. Org.
Chem. 2014, 6615.
(18) Reduction to -lactams 11; General Procedure
To a degassed ethyl acetate solution of 10 (1 equiv) was added
(10 mol%) Pd/C and the reaction flask was furnished with a H2
balloon. After stirring for 30 min, the reaction mixture was fil-
tered over Celite and evaporated. The crude residue was puri-
fied by flash column chromatography (eluent: 5% ethyl acetate
in petroleum ether).
(3S,4S)-1-(4-Chlorophenyl)-3-methyl-4-(naphthalen-2-yl)-
azetidin-2-one (11x)
(14) During the preparation of this manuscript, two independent
reports describing similar reactions of anilines and MBH car-
bonates were published. These methods use 10 mol% of -iso-
Yield: 25 mg (98%); white solid. IR (ATR): 2974, 1728, 1597,
1492, 1381, 1365, 1161, 1091, 813, 744 cm–1 1H NMR (300
.
© 2020. Thieme. All rights reserved. Synlett 2020, 31, A–F